Reversible disruption of XPO1-mediated nuclear export inhibits respiratory syncytial virus (RSV) replication
Abstract Respiratory syncytial virus (RSV) is the primary cause of serious lower respiratory tract disease in infants, young children, the elderly and immunocompromised individuals. Therapy for RSV infections is limited to high risk infants and there are no safe and efficacious vaccines. Matrix (M)...
Saved in:
Main Authors: | Cynthia Mathew, Sharon Tamir, Ralph A. Tripp, Reena Ghildyal |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/010a40d4f4ac4e098a1bb5e948447db9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis
by: Brian M. Maas, et al.
Published: (2021) -
Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
by: Asunción Mejías, et al.
Published: (2008) -
Factors Associated with Severe Lower Respiratory Tract Infection from Respiratory Syncytial Virus (RSV) in Thai Children
by: Atipotsawee Tungsupreechameth, et al.
Published: (2021) -
Inhibition of XPO-1 Mediated Nuclear Export through the Michael-Acceptor Character of Chalcones
by: Marta Gargantilla, et al.
Published: (2021) -
Seasonality, molecular epidemiology, and virulence of Respiratory Syncytial Virus (RSV): A perspective into the Brazilian Influenza Surveillance Program.
by: Lucas A Vianna, et al.
Published: (2021)